Germany has ordered 80 million doses of a vaccine made by BioNTech 22UAy.DE specifically targeting Omicron that should arrive in April or May. It has also ordered four million doses of the newly approved Novavax vaccine - seen as more acceptable to vaccine sceptics - and 11 million doses of the new Valneva shot, which is waiting for marketing authorisation, Lauterbach said.
The Novavax shots will arrive in the country in January, he added.
Germany expects Omicron to be dominant within 3 weeks
https://news-static.webullfintech.com/us/news-html/20211222/47838221.html?theme=1&color=2&hl=en&android_sdk_int=30&canary-version=&_v=1&sp=1&tickerId=913323591&disSymbol=NVAX&isSubsNews=false
UPDATE 2-Germany expects Omicron to be dominant within 3 weeks
UPDATE 2-Germany expects Omicron to be dominant within 3 weeks Adds details, background BERLIN, Dec 22 (Reuters) - The Omicron variant will become the dominant coronavirus strain in Germany within three weeks and the country has ordered 80 million doses of
news-static.webullfintech.com
'상식+ > 뉴스' 카테고리의 다른 글
| 노바백스·MSD·화이자…새 판 짜는 코로나 치료제·백신 시장 (0) | 2021.12.23 |
|---|---|
| 노바백스, 오미크론 효능 (0) | 2021.12.23 |
| "모든 변이 꼼짝마"..미군, '원샷' 백신 곧 개발 완료 (0) | 2021.12.22 |
| 이스라엘 부스터샷 접종 (4차) (0) | 2021.12.22 |
| "효능 없다" vs "확정 못해"… '노바백스 백신' 두 가지 시선 (0) | 2021.12.22 |
